International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome. The subject material appropriate for submission includes: • Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
| YEAR | Impact Factor |
|---|---|
| 2023-24 | 4.8 |
| 2022 | 0.0 |
| 2021 | 5.714 |
International Immunopharmacology, 1567-5769, 2001-ongoing, Immunology and Microbiology,Medicine,Pharmacology, Toxicology and Pharmaceutics.